跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
MoxCV 625
Approved
STANDARD
MoxCV 625
Sun Pharma Laboratories Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
db6661d94b5e2907
Company
Sun Pharma Laboratories Ltd.
Type
Standard
Approval Details
Approval Id
db6661d94b5e2907
Drug Approval Philippines Name
MoxCV 625
Product Name
MoxCV 625
Registration Number
DRP-14076
Brand Name
MoxCV 625
Generic Name
Co-Amoxiclav
Dosage Form
Film-Coated Tablet
Dosage Strength
625 mg
Manufacturer
Sun Pharma Laboratories Ltd.
Importer
Sun Pharma Philippines, Inc.
Distributor
Sun Pharma Philippines, Inc.
Company Detail Path
/organization/sun-pharma-laboratories-ltd
Issuance Date
05 June 2024
Expiry Date
14 June 2028
Pharmacologic Category
Antibacterial (Penicillin/Beta-lactamase inhibitor)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
db6661d94b5e2907
Type
Standard
Back to Philippines FDA Approvals
MoxCV 625 - Philippines FDA Drug Approval Details